Portal de investigación
Discontinuación de la monoterapia con Darunavir potenciado con Cobicistat en pacientes con el virus de la inmunodeficiencia humana.
Datos básicos
- Protocolo:
- MONDAN01
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2022
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimce.2021.05.020. 2023
Dalbavancin in clinical practice in Spain: a 2 year retrospective study.
Morata, Laura; (...); Almirante, Benito
Article. 10.1093/jacamr/dlac120. 2022
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape.
Solana-Altabella, Antonio; (...); Montesinos, Pau
Article. 10.1080/17512433.2023.2174523. 2023
Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella
Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo
Article. 10.1080/22221751.2021.2017756. 2022
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Treatment and prevention of monkeypox.
de la Calle-Prieto, Fernando; (...); Membrillo, Francisco Javier
Article. 10.1016/j.eimce.2022.12.010. 2023